|1.||Yen, Yun: 3 articles (10/2011 - 05/2006)|
|2.||Morikawa, Teppei: 2 articles (12/2010 - 12/2010)|
|3.||Fukayama, Masashi: 2 articles (12/2010 - 12/2010)|
|4.||Maeda, Daichi: 2 articles (12/2010 - 12/2010)|
|5.||Whang, Edward E: 2 articles (03/2007 - 08/2004)|
|6.||Duxbury, Mark S: 2 articles (03/2007 - 08/2004)|
|7.||Gandara, David: 2 articles (03/2007 - 05/2006)|
|8.||Juhasz, Agnes: 2 articles (03/2007 - 05/2006)|
|9.||Faridi, Jesika S: 1 article (11/2015)|
|10.||Wilson, Elizabeth A: 1 article (11/2015)|
01/01/2014 - "To investigate the implication of ribonucleotide reductase M2 (RRM2) in the carcinogenesis of uterine cervix and its relationship with clinicopathological characteristics and prognosis of cancer patients. "
01/01/2014 - "The expression of ribonucleotide reductase M2 in the carcinogenesis of uterine cervix and its relationship with clinicopathological characteristics and prognosis of cancer patients."
10/01/2011 - "Overexpression of ribonucleotide reductase M2 (hRRM2) and p53-dependent RR small subunit (p53R2) has been correlated with tumor malignancy and progression in several types of cancer. "
03/02/2007 - "The ribonucleotide reductase M2 subunit (RRM2) is a determinant of malignant cellular behavior in a range of human cancers. "
03/01/2007 - "In patients with tumor biopsies treated at the MTD, decreased ribonucleotide reductase M2 expression correlated with response. "
|2.||Stomach Neoplasms (Stomach Cancer)
12/01/2010 - "This study was conducted to investigate the roles of ribonucleotide reductase M2 subunit in gastric cancer. "
12/01/2010 - "Our data suggest that ribonucleotide reductase M2 subunit overexpression could be associated with the gastric cancer progression and that suppression of its function is a potential therapeutic strategy in gastric cancer."
12/01/2010 - "Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro."
12/01/2010 - "Among 112 gastric cancer tissues, ribonucleotide reductase M2 subunit overexpression (≥10% cancer cells stained) was observed in 72 cases (64.3%). "
12/01/2010 - "Suppression of ribonucleotide reductase M2 subunit synthesis, using small interfering RNA, inhibited the growth of 3 gastric cancer cell lines, MKN-1, MKN-7, and SNU-719. "
|3.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/01/2015 - "Ribonucleotide reductase M2 is a promising molecular target for the treatment of oral squamous cell carcinoma."
05/01/2015 - "In our previous study, ribonucleotide reductase M2 (RRM2) was identified as a cancer-related gene commonly overexpressed in human oral squamous cell carcinoma (OSCC) cell lines. "
|4.||Breast Neoplasms (Breast Cancer)
11/01/2015 - "In this study, overexpression of ribonucleotide reductase M2 (RRM2) in MCF-7 breast cancer cells resulted in a reduction in the effectiveness of tamoxifen, through downregulation of ERα66 and upregulation of the 36-kDa variant of ER (ERα36). "
11/01/2015 - "Targeting Ribonucleotide Reductase M2 and NF-κB Activation with Didox to Circumvent Tamoxifen Resistance in Breast Cancer."
|1.||Messenger RNA (mRNA)
|5.||Small Interfering RNA (siRNA)
|6.||Ribonucleotide Reductases (Ribonucleotide Reductase)
|7.||DNA (Deoxyribonucleic Acid)
|8.||STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
|9.||Epidermal Growth Factor Receptor (EGF Receptor)